Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2037)
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
46,387
Price
$10.37
Total Value
$481.03K
Shares Held After
1,319,784
% of Holdings
3.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
93,433
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
144
Price
$180.00
Total Value
$25.92K
Shares Held After
93,656
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
170,569
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
142
Price
$180.00
Total Value
$25.56K
Shares Held After
170,792
% of Holdings
0.1%
Wave Life Sciences, Inc. (WVE)
Rawcliffe Adrian — Director
Shares
12,700
Price
$5.29
Total Value
$67.18K
Shares Held After
0
% of Holdings
100.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
6,700
Price
$26.08
Total Value
$174.77K
Shares Held After
119,289
% of Holdings
5.3%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
400
Price
$167.92
Total Value
$67.17K
Shares Held After
22,979
% of Holdings
1.7%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
13,248
Price
$166.11
Total Value
$2.20M
Shares Held After
23,379
% of Holdings
36.2%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
19,014
Price
$165.16
Total Value
$3.14M
Shares Held After
36,627
% of Holdings
34.2%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
9,934
Price
$164.27
Total Value
$1.63M
Shares Held After
55,641
% of Holdings
15.1%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
3,704
Price
$163.41
Total Value
$605.29K
Shares Held After
65,575
% of Holdings
5.3%
BIODESIX INC (BDSX)
SCHULER JACK W — 10% Owner
Shares
15,000
Price
$24.47
Total Value
$366.99K
Shares Held After
555,810
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
41
Price
$520.96
Total Value
$21.36K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
679
Price
$520.38
Total Value
$353.34K
Shares Held After
324,484
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$519.49
Total Value
$602.61K
Shares Held After
325,163
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.16
Total Value
$165.81K
Shares Held After
326,323
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,249
Price
$517.21
Total Value
$646.00K
Shares Held After
326,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$516.16
Total Value
$485.19K
Shares Held After
327,892
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
893
Price
$514.87
Total Value
$459.78K
Shares Held After
328,832
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$514.18
Total Value
$286.91K
Shares Held After
329,725
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$513.02
Total Value
$618.70K
Shares Held After
330,283
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$511.75
Total Value
$277.37K
Shares Held After
331,489
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,152
Price
$511.12
Total Value
$588.81K
Shares Held After
332,031
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$509.61
Total Value
$142.69K
Shares Held After
333,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$508.86
Total Value
$223.90K
Shares Held After
333,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$507.08
Total Value
$20.28K
Shares Held After
333,903
% of Holdings
0.0%
X4 Pharmaceuticals, Inc (XFOR)
Volpone John — President
Shares
24,576
Price
$4.44
Total Value
$109.23K
Shares Held After
265,305
% of Holdings
8.5%
DEXCOM INC (DXCM)
Heller Bridgette P — Director
Shares
1,012
Price
$88.29
Total Value
$89.35K
Shares Held After
29,570
% of Holdings
3.3%
Amneal Pharmaceuticals, Inc. (AMRX)
Daly Jason B. — EVP, Chief Legal Officer
Shares
210,000
Price
$17.40
Total Value
$3.65M
Shares Held After
35,171
% of Holdings
85.7%
Zai Lab Ltd (ZLAB)
Lis William — Director
Shares
8,506
Price
$25.00
Total Value
$212.65K
Shares Held After
41,931
% of Holdings
16.9%
Merck&Co., Inc. (MRK)
Zachary Jennifer — EVP, General Counsel
Shares
80,315
Price
$133.46
Total Value
$10.72M
Shares Held After
45,509
% of Holdings
63.8%
Elanco Animal Health Inc (ELAN)
Harrington Michael J — Director
Shares
5,000
Price
$21.82
Total Value
$109.10K
Shares Held After
131,451
% of Holdings
3.8%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
47,436
Price
$4.44
Total Value
$210.83K
Shares Held After
328,651
% of Holdings
12.6%
Amneal Pharmaceuticals, Inc. (AMRX)
Shah Nikita — Executive Vice President
Shares
146,403
Price
$17.51
Total Value
$2.56M
Shares Held After
253,390
% of Holdings
36.6%
CVRx, Inc. (CVRX)
Binkowski Brent — CHIEF OPERATING OFFICER
Shares
1,309
Price
$2.55
Total Value
$3.34K
Shares Held After
30,291
% of Holdings
4.1%
Embecta Corp. (EMBC)
HOMBACH ROBERT J. — Director
Shares
45,000
Price
$4.97
Total Value
$223.85K
Shares Held After
109,587
% of Holdings
41.1%
Embecta Corp. (EMBC)
Mann Jeffrey Z — Pres, Pharm Svc&Prod Mgmt, CLO
Shares
20,000
Price
$4.99
Total Value
$99.80K
Shares Held After
262,915
% of Holdings
7.6%
Embecta Corp. (EMBC)
Elguicze Jacob — SVP and CFO
Shares
20,000
Price
$4.67
Total Value
$93.36K
Shares Held After
309,139
% of Holdings
6.5%
Embecta Corp. (EMBC)
Kurdikar Devdatt — Director
Shares
30,000
Price
$4.70
Total Value
$140.94K
Shares Held After
804,919
% of Holdings
3.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,102
Price
$359.12
Total Value
$5.06M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,899
Price
$358.41
Total Value
$7.49M
Shares Held After
14,102
% of Holdings
59.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,396
Price
$357.63
Total Value
$5.51M
Shares Held After
35,001
% of Holdings
30.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,515
Price
$356.43
Total Value
$896.43K
Shares Held After
50,397
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,980
Price
$354.71
Total Value
$702.32K
Shares Held After
52,912
% of Holdings
3.6%
ARTIVION, INC. (AORT)
Holloway Jean F — SVP, General Counsel
Shares
977
Price
$28.49
Total Value
$27.83K
Shares Held After
184,118
% of Holdings
0.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
11,048
Price
$27.25
Total Value
$301.06K
Shares Held After
92,211
% of Holdings
10.7%
Omada Health, Inc. (OMDA)
Shao Wei-Li — President
Shares
8,866
Price
$25.02
Total Value
$221.80K
Shares Held After
307,372
% of Holdings
2.8%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
600
Price
$132.04
Total Value
$79.22K
Shares Held After
110,167
% of Holdings
0.5%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
11,099
Price
$131.61
Total Value
$1.46M
Shares Held After
110,767
% of Holdings
9.1%
Showing 401–450 of 2037 transactions (page 9 of 41)